| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 35.439 | 54.161 | 92.158 | 93.015 | 83.534 |
| Total Income - EUR | - | - | - | - | - | 35.446 | 54.176 | 92.188 | 93.026 | 88.567 |
| Total Expenses - EUR | - | - | - | - | - | 4.646 | 8.989 | 9.460 | 17.992 | 47.900 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 30.800 | 45.188 | 82.728 | 75.034 | 40.666 |
| Net Profit/Loss - EUR | - | - | - | - | - | 29.817 | 43.850 | 80.872 | 74.123 | 38.536 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Vanprest Anestezie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 50.191 | 81.801 |
| Current Assets | - | - | - | - | - | 30.358 | 44.538 | 81.343 | 55.541 | 37.299 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 60.833 | 2.652 | 37.018 |
| Cash | - | - | - | - | - | 30.358 | 44.538 | 20.509 | 52.889 | 280 |
| Shareholders Funds | - | - | - | - | - | 29.858 | 43.890 | 80.913 | 74.163 | 38.576 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 499 | 648 | 430 | 20.955 | 63.536 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 10.614 | 16.987 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Vanprest Anestezie S.r.l.